Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

FPC Capital Requirements

20 Jun 2013 07:08

RNS Number : 4621H
Royal Bank of Scotland Group PLC
20 June 2013
 



 

 

The Royal Bank of Scotland Group plc

 

20 June 2013

 

Statement on the completion of the UK Regulators capital shortfall exercise

 

The Royal Bank of Scotland Group plc ("RBS", "the Group") notes today's announcement by the Prudential Regulatory Authority ("PRA") on the completion of its capital shortfall exercise across major UK banks and building societies.

 

As indicated in its earlier release, dated 22 May, RBS expects to continue to improve its Core Tier 1 capital ("CT1") ratio during 2013 through continued delivery against its established business plan.

 

RBS continues to target a 'fully loaded' Basel 3 CT1 ratio of around 9% by year end 2013, after including the provision of capital to fund anticipated future loan growth.

 

Further details of RBS's plans and a reconciliation to the results published by the PRA today are provided below in the Appendix to this announcement.

 

For further information contact:

 

RBS Group Investor Relations

Richard O'Connor

Head of Investor Relations

+44 207 672 1758

RBS Group Media Relations

Michael Strachan

Deputy Head of Group Media Relations

+44 131 523 4205

 

Appendix to statement:

Reconciliation with RBS Group plc published ratios and 2013 glidepath

 

The PRA's original assessment of RBS's capital adequacy, under the FPC's recommendations, is outlined in the table below. RBS's position, factoring in business plans and actions announced at the FY12 results and Q113 IMS, is presented alongside this.

RBS's position takes into account the Group's previously announced repositioning of its Markets business and the planned continued reduction of Non-Core exposures, as well as other actions. While the Group's intention to partially IPO Citizens was announced in consideration of the PRA capital exercise, it is not factored into the 2013 capital actions.

The principal adjustments that RBS applied to the PRA December 2012 start point are:

1) the RBS assumption around counterparty credit model acceptance that a) brings RBS in line with peers and b) has been worked on for two years, with acceptance expected prior to CRDIV implementation at the start of 2014;

2) Latest Capital Requirements Directive IV ("CRDIV") changes, which exempt EU corporates, pension funds and sovereign exposures from CVA volatility charge, confirmation of which was announced post the original PRA analysis.

By the end of 2013, the PRA capital requirement under the FPC exercise of £3.2bn is targeted to be reduced to £0.4bn. Several actions contribute to this including Markets downsizing, several small planned divestments and LME gains.

 

 

 

 

 

RBS capital requirements compared to PRA view

Reference

Per PRA

RBS

 

£bn

£bn

End 2012 position

Core Capital Resources (CET1 Basel 3)

37.2

Reported RWAs (Basel 3)

567.9

End 2012 CET1 Ratio

6.5%

Known capital adjustments

Note 2

1.0

Known/expected RWA adjustments

Note 3

(72.9)

Core Capital Resources (CET1 Basel 3)

38.2

Reported RWAs (Basel 3)

495.0

CET1 Ratio (as published by RBS)

Note 1

7.7%

PRA adjustments

PRA adjustments to capital resources for expected future losses and an assessment of future cost of conduct redress

(7.1)

(7.1)

PRA adjustments to RWAs to reflect a more prudent calculation of risk weights

56.3

56.3

Capital actions

Total CET1 equivalent of capital actions required of RBS

13.6

7.5

CET1 equivalent actions in RBS's plans

10.4

7.1

Additional capital action requirement planned by RBS to meet the PRA 7% as of December 2013

Note 4

3.2

0.4

 

 

Note 1: CET1 Basel 3 capital position as of December 2012

Reference

Capital

RWA

%

£bn

£bn

PRA

37.2

567.9

6.5%

Adjustments:

 

- Capital base changes

Note 2

1.0

0.2%

- Counterparty risk IMM model extension

Note 3

(47.0)

0.6%

- Reduction in counterparty risk due to CRDIV CVA changes

Note 3

(36.0)

0.5%

- Other

Note 3

10.1

(0.1)%

RBS (as published)

a

38.2

495

7.7%

 

 

a Note that Deferred Tax Asset deduction is taken in full: with an impact of 70bps on CT1. The real capital benefit of this asset for RBS will emerge over the next 5 years as the Group returns to profitability.

 

 

 

Note 2: The end 2012 capital base variance of £1bn is due to:

 

i) securitisation treated as RWAs rather than a deduction;

ii) offset principally by higher actual provisions taken in Q4 2012 for conduct risk relative to forecast used by the PRA.

 

Note 3: The RWA adjustment of £72.9bn represents RBS assumption around counterparty credit model acceptance that a) brings RBS in line with peers and b) has been worked on for two years with approval expected shortly; and latest CRDIV changes reflected by RBS but not by the PRA given timing of the exercise. In addition, this also includes impact of securitisation treated as RWA rather than a deduction.

Reference

£bn

£bn

 

RWAs per PRA (Dec-12 Flash)

567.9

Counterparty risk IMM model extension

(47.0)

Reduction in counterparty risk due to CRDIV text changes

b

(36.0)

Net Other (including securitisation treated as RWA)

10.1

(72.9)

RWAs - as adjusted

495.0

 

 

Note 4: RBS actions to address remaining gap

Factoring in business plans announced at the FY12 results, Q113 IMS and remaining planned capital actions, RBS's capital shortfall reduces to £0.4bn, which the Group plans to fully satisfy in early 2014.

Reference

Per PRA

Per RBS

£bn

£bn

Total Capital actions required

13.6

7.5

Adjustments for models & EU exemptions

(6.1)

-

7.5

7.5

Q1 2013 progress on fully loaded ratio

(2.4)

Q2-Q4 2013 planned actions

RWA reduction (including Non Core rundown & Markets reshape)

(3.0)

Reduction in excess Expected Loss over provision

(1.0)

Other capital movements

c

(0.7)

Total Q2-Q4 2013 planned actions

(4.7)

Total 2013 actions

(7.1)

Post planned actions capital requirement

d

0.4

 

 

 

b CRDIV final text includes exemption for EU corporates, pension funds and sovereigns from CVA volatility charge in RWA calculations.

cCapital base movement includes, among other things, use of consensus profit forecast, expected gains on small disposals and liability management exercises.

d Remaining gap of £0.4bn to be closed through Q1 2014 profit generation and continuing benefits of Markets re-sizing. Planned IPO of Citizens provides further comfort.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCNKKDKABKKQAB
Date   Source Headline
5th Nov 20184:21 pmRNSPublication of Suppl.Prospcts
2nd Nov 20185:25 pmRNSPublication of 2018 EBA EU-wide stress test result
2nd Nov 20182:10 pmRNSDirector/PDMR Shareholding
1st Nov 20187:00 amRNSUK intra-Group capital & liquidity arrangements
31st Oct 20182:38 pmRNSTotal Voting Rights
31st Oct 20187:00 amRNSDividend Declaration
30th Oct 20184:05 pmRNSDirector/PDMR Shareholding
29th Oct 20183:46 pmRNSDirector/PDMR Shareholding
26th Oct 20187:00 amRNSInterim Management Statement
9th Oct 20182:07 pmRNSForm 8.3 - CareTech Holdings
4th Oct 201812:43 pmRNSForm 8.3 - CareTech Holdings
4th Oct 201812:25 pmRNSBLOCK LISTING SIX MONTHLY RETURN
1st Oct 20183:00 pmRNSDirector/PDMR Shareholding
28th Sep 201812:32 pmRNSTotal Voting Rights
25th Sep 201811:23 amRNSPricing of USD Fixed Rate to Floating Rate Notes
25th Sep 20187:00 amRNSBofAML Annual Financial CEO Conference
24th Sep 20189:00 amRNSRBS Investor SeminarUK Personal & Business Banking
17th Sep 201812:05 pmRNSPublication of Final Terms
13th Sep 201812:25 pmRNSForm 8.3 - CareTech Holdings
13th Sep 20188:00 amRNSBarclays Global Financial Services Conference
3rd Sep 20186:00 pmRNSPublication of Final Terms
31st Aug 20184:42 pmRNSTotal Voting Rights
31st Aug 20184:15 pmRNSNatWest Markets N.V. Interim Results 2018
22nd Aug 20185:01 pmRNSDividend Declaration
21st Aug 20183:32 pmRNSPublication of Suppl.Prospcts
17th Aug 20187:00 amRNSDirectorate Change
15th Aug 20187:00 amRNSDeclaration of Interim Dividend
13th Aug 20189:00 amRNSUpdate on ring-fencing plans
3rd Aug 20182:25 pmRNSForm 8.3 - [CareTech Holdings]
3rd Aug 20187:00 amRNSHalf-year Report
31st Jul 20182:44 pmRNSUpdate on ring-fencing plans
31st Jul 201812:04 pmRNSTotal Voting Rights
26th Jul 201812:17 pmRNSForm 8.3 - CareTech Holdings PLC
23rd Jul 20182:10 pmRNSForm 8.3 - CareTech Holdings plc
17th Jul 201811:46 amRNSRBS welcomes credit ratings action by Moody's
16th Jul 20186:18 pmRNSAllotment and Issue of New Ordinary Shares
16th Jul 20184:18 pmRNSForm 8.3 - CareTech Holdings plc
2nd Jul 20182:47 pmRNSCapital reduction - notice of completion
29th Jun 201812:51 pmRNSTotal Voting Rights
27th Jun 20184:36 pmRNSHolding(s) in Company
25th Jun 201811:52 amRNSPublication of Final Terms
22nd Jun 20185:28 pmRNSPublication of Final Terms
21st Jun 201811:52 amRNSPricing of USD Dual-Tranche Notes
8th Jun 20189:23 amRNSTR-1 Notification of major shareholdings
7th Jun 20189:00 amRNSGoldman Sachs European Financials Conference
5th Jun 20187:00 amRNSDisposal of approximately 7.7% of RBS Group plc.
4th Jun 20184:36 pmRNSIntention to dispose of c7.7% of RBS Group plc.
31st May 20185:32 pmRNSTotal Voting Rights
31st May 20184:30 pmRNSRBS notes credit rating actions by Standard&Poor's
31st May 201812:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.